GlassScriptPhysician profile
Paul Liswood
NPI 1740394600
$3,554.02
in general payments reported to CMS, 2019-2025
18 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $507 · 2021: $438 · 2022: $263 · 2023: $955 · 2024: $329 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,771.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Royal Biologics, INC. | $427.84 | 2020-2021 | |
| Abbott Laboratories | $408.27 | 2019-2022 | |
| Novastep INC. | $354.54 | 2023 | Peca Bunion Correction System |
| Kerecis Limited | $319.11 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Nevro Corp. | $293.23 | 2023 | Senza |
| Smith+Nephew, INC. | $286.31 | 2023-2025 | Regranex, Allevyn Heel 10.5cm X 13.5cm Ctn 5, Pico |
| Zimmer Biomet Holdings, INC. | $153.55 | 2019-2021 | |
| Averitas Pharma INC. | $153.50 | 2024-2025 | Qutenza |
| Wright Medical Technology, INC. | $136.89 | 2020 | |
| Organogenesis INC. | $125.00 | 2020 | |
| Paratek Pharmaceuticals, INC. | $125.00 | 2024 | Nuzyra |
| Amgen INC. | $125.00 | 2025 | Krystexxa |
| Stability Biologics, LLC | $123.70 | 2021 | |
| Treace Medical Concepts, INC. | $121.91 | 2022 | |
| Kci USA, INC. | $121.43 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gramercy Extremity Orthopedics LLC | $114.66 | 2023 | |
| Baxter Healthcare | $87.74 | 2019 | |
| Medtronic Vascular, INC. | $76.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Liswood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.